Infliximab-associated lymphoproliferative disorders.
Hoshida
Yoshihiko
Y
Yamamoto
Shigeo
S
Wada
Naoki
N
Xu
Jing-Xian
JX
Sasaki
Toru
T
Aozasa
Katsuyuki
K
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D005260:Female; D006801:Humans; D000069285:Infliximab; D008232:Lymphoproliferative Disorders / Q000139:chemically induced*; D008875:Middle Aged; D012307:Risk Factors
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab